ECHA management board elects new deputy chairman

Martin Lynch takes the role

You may also like

Ingredients
GELITA launches ultra-low endotoxin MEDELLAPRO grade targeting sensitive biomedical applications

GELITA launches ultra-low endotoxin MEDELLAPRO grade targeting sensitive biomedical applications

The new gelatin excipient, featuring less than ten endotoxin units per gram, expands GELITA's ECE portfolio for drug delivery, vaccine stabilisation and 3D bioprinting, alongside recombinant animal-free collagen development
Ingredients
Safe and accurate flow measurement for pharmaceutical production

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing
NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
Ingredients
Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Ingredients
The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)

The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)

Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the system has evolved into a stable but more complex dual framework
Subscribe now